Zimmer Biomet to Report Q4 Earnings: Here's What to Expect — Positive

ZBH   Zacks Investment Research — February 03, 2026

ZBH is set to report Q4 on Feb. 10, with revenues seen at $2.20B and EPS at $2.38 as hips, knees, robotics and S.E.T. drive growth estimates.

image for news Zimmer Biomet to Report Q4 Earnings: Here's What to Expect

Landmark Bancorp Q4 Earnings Rise Y/Y on Strong Margins — Positive

LARK   Zacks Investment Research — February 03, 2026

LARK reported higher Q4 earnings year over year, driven by strong net interest income, margin expansion and improved profitability metrics.

image for news Landmark Bancorp Q4 Earnings Rise Y/Y on Strong Margins

Will Reblozyl Shine in Bristol Myers' Fourth-Quarter Results? — Positive

BMY   Zacks Investment Research — February 03, 2026

BMY leans on fast-growing Reblozyl, now a $2B+ franchise, to fuel results as generics pressure legacy drugs ahead of Q4 earnings.

image for news Will Reblozyl Shine in Bristol Myers' Fourth-Quarter Results?

TransDigm's Q1 Earnings Surpass Estimates, Sales Increase Y/Y — Positive

TDG   Zacks Investment Research — February 03, 2026

TDG beats Q1 earnings and sales estimates as revenues jump 14%. It also raises its fiscal 2026 sales and adjusted EPS guidance.

image for news TransDigm's Q1 Earnings Surpass Estimates, Sales Increase Y/Y

APELY or VPG: Which Is the Better Value Stock Right Now? — Positive

APELY  VPG   Zacks Investment Research — February 03, 2026

Investors with an interest in Electronics - Miscellaneous Components stocks have likely encountered both Alps Electric (APELY) and Vishay Precision (VPG). But which of these two stocks presents investors with the better value opportunity right now?

image for news APELY or VPG: Which Is the Better Value Stock Right Now?

NMR or MKTX: Which Is the Better Value Stock Right Now? — Positive

MKTX  NMR   Zacks Investment Research — February 03, 2026

Investors with an interest in Financial - Investment Bank stocks have likely encountered both Nomura Holdings (NMR) and MarketAxess (MKTX). But which of these two companies is the best option for those looking for undervalued stocks?

image for news NMR or MKTX: Which Is the Better Value Stock Right Now?

GMED vs. PEN: Which Stock Is the Better Value Option? — Neutral

GMED  PEN   Zacks Investment Research — February 03, 2026

Investors looking for stocks in the Medical - Instruments sector might want to consider either Globus Medical (GMED) or Penumbra (PEN). But which of these two stocks is more attractive to value investors?

image for news GMED vs. PEN: Which Stock Is the Better Value Option?

SGIOY vs. ZTS: Which Stock Is the Better Value Option? — Neutral

SGIOY  ZTS   Zacks Investment Research — February 03, 2026

Investors interested in stocks from the Medical - Drugs sector have probably already heard of Shionogi & Co., Ltd. Unsponsored ADR (SGIOY) and Zoetis (ZTS).

image for news SGIOY vs. ZTS: Which Stock Is the Better Value Option?

NVZMY vs. HWKN: Which Stock Is the Better Value Option? — Neutral

HWKN  NVZMY   Zacks Investment Research — February 03, 2026

Investors looking for stocks in the Chemical - Specialty sector might want to consider either Novozymes A/S (NVZMY) or Hawkins (HWKN). But which of these two stocks offers value investors a better bang for their buck right now?

image for news NVZMY vs. HWKN: Which Stock Is the Better Value Option?

EDU or UTI: Which Is the Better Value Stock Right Now? — Neutral

EDU  UTI   Zacks Investment Research — February 03, 2026

Investors looking for stocks in the Schools sector might want to consider either New Oriental Education (EDU) or Universal Technical Institute (UTI). But which of these two stocks presents investors with the better value opportunity right now?

image for news EDU or UTI: Which Is the Better Value Stock Right Now?

DTEGY or TLK: Which Is the Better Value Stock Right Now? — Neutral

DTEGY  TLK   Zacks Investment Research — February 03, 2026

Investors looking for stocks in the Diversified Communication Services sector might want to consider either Deutsche Telekom AG (DTEGY) or PT Telekomunikasi (TLK). But which of these two stocks offers value investors a better bang for their buck right now?

image for news DTEGY or TLK: Which Is the Better Value Stock Right Now?

UGP or KMI: Which Is the Better Value Stock Right Now? — Neutral

KMI  UGP   Zacks Investment Research — February 03, 2026

Investors with an interest in Oil and Gas - Production and Pipelines stocks have likely encountered both Ultrapar Participacoes S.A. (UGP) and Kinder Morgan (KMI).

image for news UGP or KMI: Which Is the Better Value Stock Right Now?

Citi analyst John Godyn considers all of the airlines he covers to be high-risk investments, except for one.

image for news Two airline stocks are favored by Citi for the short haul, but Delta might be a lower-risk play

Top Performing Leveraged/Inverse ETFs: 02/01/2026 — Neutral

BOIL  DUST  DZZ  ETHD  FBL  GDXD  JDST  OILU  SBIT  UCO   ETF Trends — February 03, 2026

Top Performing Levered/Inverse ETFs Last Week These were last week's top performing leveraged and inverse ETFs. Note that because of leverage, these kinds of funds can move quickly.

image for news Top Performing Leveraged/Inverse ETFs: 02/01/2026

Global Technology Firm Selected to Lead Mission-Critical Digital Infrastructure Modernization for the Heavy Equipment Leader SOMERSET, N.J., Feb. 3, 2026 /PRNewswire/ -- ACI, a global provider of enterprise-grade technology services, today announced it has entered into a multi-year, strategic partnership with Caterpillar Inc. (NYSE: CAT).

image for news ACI Wins Multi-Year Caterpillar Engagement as Strategic Technology Transformation Partner

GE HealthCare Stock Before Q4 Earnings: To Buy or Not to Buy? — Positive

GEHC   Zacks Investment Research — February 03, 2026

GEHC heads into fourth-quarter earnings with steady demand and strong product momentum, though tariffs and investments may keep margins in focus.

image for news GE HealthCare Stock Before Q4 Earnings: To Buy or Not to Buy?

Pfizer Stock Slides Despite Q4 Earnings Beat and New Obesity Drug Data — Negative

PFE   Zacks Investment Research — February 03, 2026

PFE shares fall even after Q4 earnings beat on COVID product declines and muted investor reaction to new obesity drug data.

image for news Pfizer Stock Slides Despite Q4 Earnings Beat and New Obesity Drug Data

Sally Beauty to Report Q1 Earnings: Key Factors to Watch Ahead — Positive

SBH   Zacks Investment Research — February 03, 2026

SBH is set to report Q1 results, expecting modest sales growth, resilient margins and digital momentum, but cautious consumer demand remains a key watch point.

image for news Sally Beauty to Report Q1 Earnings: Key Factors to Watch Ahead

Gartner Earnings Outpace Estimates in Q4, Revenues Rise Y/Y — Positive

IT   Zacks Investment Research — February 03, 2026

IT beats fourth-quarter 2025 earnings and revenue estimates as Insights and Conferences deliver solid growth, offsetting a sharp y/y drop in EPS.

image for news Gartner Earnings Outpace Estimates in Q4, Revenues Rise Y/Y

Innodata Bets on Agentic AI: Is it the Next Revenue Wave? — Positive

INOD   Zacks Investment Research — February 03, 2026

INOD rides on the Agentic AI wave with "judge" systems fueling recurring revenue and 45% growth outlook for 2025.

image for news Innodata Bets on Agentic AI: Is it the Next Revenue Wave?